Dyne Therapeutics, Inc. · NASDAQ:DYN
Atlas Venture Fund XI, L.P.'s stake in Dyne Therapeutics, Inc. fell to 2.40% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
Atlas Venture Fund XI, L.P.'s stake in Dyne Therapeutics, Inc. fell to 2.40%, 4,476,487 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 2.40%
- Shares
- 4,476,487
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Atlas Venture Fund XI, L.P. | 2.40% | 4,476,487 |
| Atlas Venture Associates XI, L.P. | 2.40% | 4,479,449 |
| Atlas Venture Associates XI, LLC | 2.40% | 4,479,449 |
| Atlas Venture Opportunity Fund I, L.P. | 0.50% | 975,931 |
| Atlas Venture Associates Opportunity I, L.P. | 0.50% | 975,931 |
| Atlas Venture Associates Opportunity I, LLC | 0.50% | 975,931 |
| Atlas Venture Opportunity Fund II, L.P. | 0.70% | 1,344,719 |
| Atlas Venture Associates Opportunity II, L.P. | 0.70% | 1,344,719 |
| Atlas Venture Associates Opportunity II, LLC | 0.70% | 1,344,719 |
Source
Related
- Dyne Therapeutics, Inc.
- Atlas Venture Fund XI, L.P.
- Dyne Therapeutics, Inc. shareholders
- Schedule 13G/A · Atlas Venture Fund XI, L.P. · Nov 13, 2025
- Form 4 · Kerr Douglas · Oct 22, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026